83027-0150 NDC - VIRI SODE (CYTOMEGALOVIRUS NOSODE, HERPES SIMPLEX I NOSODE, HERPES SIMPLEX II NOSODE, INFLUENZINUM (2024-2025), RUBELLA NOSODE, HEPATITIS A NOSODE, HEPATITIS B NOSODE, HEPATITIS C NOSODE, EPSTEIN BARR VIRUS NOSODE, HERPES ZOSTER NOSODE)

Drug Information

  • Product NDC: 83027-0150
  • Proprietary Name: Viri Sode
  • Non Proprietary Name: Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode
  • Active Ingredient(s): 30 [hp_X]/mL HEPATITIS A VIRUS; 30 [hp_X]/mL HEPATITIS B VIRUS; 30 [hp_X]/mL HEPATITIS C VIRUS; 16 [hp_X]/mL HUMAN HERPESVIRUS 1; 16 [hp_X]/mL HUMAN HERPESVIRUS 2; 15 [hp_C]/mL HUMAN HERPESVIRUS 3; 15 [hp_C]/mL HUMAN HERPESVIRUS 4; 16 [hp_X]/mL HUMAN HERPESVIRUS 5; 15 [hp_C]/mL INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); 15 [hp_C]/mL INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); 15 [hp_C]/mL INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; 15 [hp_C]/mL INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; 16 [hp_X]/mL RUBELLA VIRUS
  • Administration Route(s): ORAL
  • Dosage Form(s): SPRAY

Labeler Information

Field Name Field Value
Labeler Name: Nutritional Specialties, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:6/3/2025

Package Information

No. Package Code Package Description Billing Unit
183027-0150-160 mL in 1 BOTTLE, SPRAY (83027-0150-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC83027-0150The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEViri SodeThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMECytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex II Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster NosodeThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESPRAYThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/3/2025This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENutritional Specialties, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEHEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; RUBELLA VIRUSAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 30; 30; 16; 16; 15; 15; 16; 15; 15; 15; 15; 16 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code